CCCC Financials
C4 Therapeutics Inc - Financial statements & key metrics
Stock Price
$0.00
Market Cap
$425.68M
Income Statement Highlights
Most Recent Quarter: 2024-12-31
Revenue
$35.58M
Gross Profit
-
Operating Income
-
Net Income
$-105.32M
EPS (Diluted)
$-1.52
Balance Sheet Highlights
Total Assets
$349.60M
Total Liabilities
$133.62M
Shareholders Equity
-
Cash & Equivalents
$55.50M
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
$-65.16M
CapEx
-
Free Cash Flow
-
Profitability Metrics
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is CCCC revenue?
CCCC's most recent quarterly revenue was $35.58M. Annual revenue can be calculated by summing the four most recent quarters.
Is CCCC profitable?
CCCC reported a loss of $105.32M in the most recent quarter.
What is CCCC market cap?
CCCC has a market capitalization of $425.68M, making it a small-cap stock.
Does CCCC have debt?
View CCCC's balance sheet for debt information.
What is CCCC cash flow?
Cash flow data is available in the full financial statements.